Platinum Investment Management LTD Exagen Inc. Transaction History

Platinum Investment Management LTD

  • $2.16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$2.1 - $3.4 $182,576 - $295,599
-86,941 Reduced 24.76%
264,130 $633,000
Q3 2022

Nov 14, 2022
SELL
$2.69 - $8.68 $131,619 - $424,703
-48,929 Reduced 12.23%
351,071 $951,000
Q1 2021

May 13, 2021
BUY
$13.9 - $22.0 $5.56 Million - $8.8 Million
400,000 New
400,000 $7 Million

Others Institutions Holding XGN

# of Institutions
38
Shares Held
6.41M
Call Options Held
4.5K
Put Options Held
400
View Full List

About EXAGEN INC.

XGN Quotes by TradingView
  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $89.8M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email